186 related articles for article (PubMed ID: 9239608)
1. Development of oncology protocol using fluorine-18-FDG: one center's experience.
Cronin V; Galantowicz P; Nabi HA
J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608
[TBL] [Abstract][Full Text] [Related]
2. [Cost-effective PET scans in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O
Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909
[TBL] [Abstract][Full Text] [Related]
3. PET scans of abdominal malignancy.
Blahd WH; Brown CV; Khonsary SA; Farahi JB; Quinones N; Ribe JY; Coyle JJ; Glass EC; Mandelkern MA
World J Surg; 1996 Feb; 20(2):245-7. PubMed ID: 8661826
[TBL] [Abstract][Full Text] [Related]
4. [Cost-effective PET investigations in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O
Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917
[TBL] [Abstract][Full Text] [Related]
5. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
[TBL] [Abstract][Full Text] [Related]
6. PET FDG studies in oncology.
Hawkins RA; Hoh CK
Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
[TBL] [Abstract][Full Text] [Related]
7. Clinical role of positron emission tomography in oncology.
Bomanji JB; Costa DC; Ell PJ
Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566
[TBL] [Abstract][Full Text] [Related]
8. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Shreve PD; Steventon RS; Deters EC; Kison PV; Gross MD; Wahl RL
Radiology; 1998 May; 207(2):431-7. PubMed ID: 9577492
[TBL] [Abstract][Full Text] [Related]
9. [Positron-emission tomography in oncology].
Zaplatnikov K; Menzel C; Döbert N; Diehl M; Hamscho N; Grünwald F
Klin Med (Mosk); 2003; 81(12):13-21. PubMed ID: 14971150
[TBL] [Abstract][Full Text] [Related]
10. [Cost effectiveness analysis of FDG-PET in the differential diagnosis and staging of lung cancer in Japan].
Kubota K; Yamada S; Fukuda H; Tanida T; Saitou Y; Takahashi J; Yamada K
Kaku Igaku; 1997 May; 34(5):329-36. PubMed ID: 9248260
[TBL] [Abstract][Full Text] [Related]
11. F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Zimny M; Kaiser HJ; Cremerius U; Sabri O; Schreckenberger M; Reinartz P; Büll U
Nuklearmedizin; 1999; 38(4):108-14. PubMed ID: 10392375
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
Czech N; Brenner W; Kampen WU; Henze E
Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
[No Abstract] [Full Text] [Related]
13. Clinical applications of PET in oncology.
Rohren EM; Turkington TG; Coleman RE
Radiology; 2004 May; 231(2):305-32. PubMed ID: 15044750
[TBL] [Abstract][Full Text] [Related]
14. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras.
Weber W; Young C; Abdel-Dayem HM; Sfakianakis G; Weir GJ; Swaney CM; Gates M; Stokkel MP; Parker A; Hines H; Khanvali B; Liebig JR; Leung AN; Sollitto R; Caputo G; Wagner HN
J Nucl Med; 1999 Apr; 40(4):574-8. PubMed ID: 10210215
[TBL] [Abstract][Full Text] [Related]
15. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA
Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of cancers by FDG-PET].
Ichiya Y
Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
[No Abstract] [Full Text] [Related]
17. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
[TBL] [Abstract][Full Text] [Related]
18. Use of positron emission tomography in oncology.
Glaspy JA; Hawkins R; Hoh CK; Phelps ME
Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
[TBL] [Abstract][Full Text] [Related]
19. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
[TBL] [Abstract][Full Text] [Related]
20. Cancer or inflammation? A Holy Grail for nuclear medicine.
Larson SM
J Nucl Med; 1994 Oct; 35(10):1653-5. PubMed ID: 7931666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
